Physician profile
Richard E Hrdlicka
NPI 1164595146
$3,889.14
in general payments reported to CMS, 2019-2025
25 companies · $996 in 2025
The $996 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $109 · 2021: $174 · 2022: $595 · 2023: $892 · 2024: $1,001 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,889.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $783.27 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $542.62 | 2020-2025 | |
| Glaxosmithkline, LLC. | $482.00 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $432.93 | 2020-2025 | Airsupra, Farxiga |
| Pfizer INC. | $289.88 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $187.83 | 2022-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.87 | 2020-2025 | Jardiance, Synjardy, Tradjenta |
| Ars Pharmaceuticals Operations, INC. | $159.44 | 2025 | Neffy |
| Novo Nordisk INC | $128.30 | 2022-2025 | Rybelsus, Ozempic |
| Kaleo, INC. | $103.99 | 2019-2021 | |
| Genzyme Corporation | $87.28 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $83.40 | 2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $71.31 | 2021-2023 | Xarelto |
| Inspire Medical Systems, INC. | $63.20 | 2024-2025 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $50.58 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $41.14 | 2023-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $36.91 | 2022-2023 | |
| Amarin Pharma, INC. | $31.16 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $30.24 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $25.53 | 2022 | |
| Boston Scientific Corporation | $20.41 | 2023 | Watchman Access System |
| Acella Pharmaceuticals, LLC | $17.33 | 2025 | NP Thyroid 60 |
| Ibsa Pharma INC. | $16.75 | 2025 | Licart, Flector, Tirosint |
| Alk-Abello, INC | $16.70 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Hrdlicka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.